A double-blind, randomised, placebo controlled cross-over study to compare the bronchodilatory effect of formoterol inhaled via two different Turbuhaler devices.

Study identifier:SD-037-0287

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A double-blind, randomised, placebo controlled cross-over study to compare the bronchodilatory effect of formoterol inhaled via two different Turbuhaler devices.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Apr 1999
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria